Ann: June 2023 Quarterly Update and Appendix 4C, page-38

I wouldn't worry about trying to shoot bogeyman in the dark Shell...If you can't see it...Does it exist?

Sure there's manipulation but we can only ever speculate.

I'm of the opinion, the only rational thing to do is follow the data.

Look at 'Race Oncology'...$4 to $1.27? It's not a PTX problem...It's a biotech problem.

The sp is at the mercy of its macro environment currently...When the worm turns the entire sector will feel it...Your investment could be flourishing again and be back well above water.

Critically we are well funded enough to wait for the market tides to return...Be it 6 months or two years...When inflation is categorically under wraps, I think the money will begin to flow again.

But this doesn't all mean Steven has free reign...He still needs to keep the company performing and on track...Importantly he needs to continually bring investors on the journey...That means ensure we understand where each project currently is, where they are heading.

Cheers.